Skip to main content
Clinical Trials/CTRI/2015/05/005769
CTRI/2015/05/005769
Completed
未知

An Observational, Cross sectional Study to assess the prevalence of chronic kidney disease in Type 2 Diabetes Patients in India - START- India

AstraZeneca Pharma India Ltd0 sites3,000 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
AstraZeneca Pharma India Ltd
Enrollment
3000
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • Known cases of T2DM.
  • Male and female patients aged 18 years and above
  • Must provide written Informed consent.

Exclusion Criteria

  • Patients with known type\-1 diabetes.
  • Patients with any form of acute kidney injury based on investigatorâ??s discretion.
  • Patients on maintenance dialysis or known renal transplant patients.
  • Patients with symptomatic Urinary Tract Infection (UTI) or with history of hematuria.

Outcomes

Primary Outcomes

Not specified

Similar Trials